Sangamo stock price today

Apr 01, 2020 · Sangamo Therapeutics, Inc. (SGMO), a genomic medicine company, announced today that management will present at the following investor conferences: Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics (SGMO) website in the Investors and Media section under Events and Presentations.The presentation will also be available on the Sangamo … Sangamo Therapeutics, Inc. | Pioneering Genetic Cures

8 Dec 2019 (NASDAQ:SGMO) share price is 264% higher than it was three years ago. How nice for those who held the stock! And in the last month, the share  SGMO Stock Price | Sangamo Therapeutics Inc. Stock Quote ... SGMO | Complete Sangamo Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Sangamo Therapeutics - SGMO - Stock Price & News | The ... Real time Sangamo Therapeutics (SGMO) stock price quote, stock graph, news & analysis. SGMO Stock | SANGAMO THERAPEUTICS Stock Price Today ...

SGMO | Sangamo Therapeutics Inc. Stock Price & News - WSJ

Sangamo Therapeutics Inc Stock Quote: SGMO Stock News ... Nov 01, 2019 · SGMO, Sangamo Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Gene Editing Is Coming: Get In Front Of Sangamo ... Jul 19, 2018 · Moby Dick. There is a fascinating chase for finding companies that the market, due to its necessity to discount all potential outcomes, cannot properly price. Stock Comparison: Compare Sangamo Therapeutics, Inc. (SGMO ...

SGMO - Stock quote for SANGAMO THERAPEUTICS, INC. - MSN …

SGMO: Get the latest Sangamo Therapeutics stock price and detailed information including SGMO news, historical charts and realtime prices. Sangamo Therapeutics, Inc. (SGMO) Stock Price, Quote ...

SGMO Stock Quote of Sangamo Therapeutics - InvestorPlace

Sangamo Therapeutics Price Target & Analyst Ratings ... Nov 05, 2019 · 3 Wall Street analysts have issued ratings and price targets for Sangamo Therapeutics in the last 12 months. Their average twelve-month price target is $13.00, suggesting that the stock has a possible upside of 109.34%. The high price target for SGMO is $16.00 and the low price target for SGMO is … Why Sangamo Therapeutics Stock Is Down More than 22% Today ... Sep 05, 2018 · SGMO stock activity. Today, Sangamo Therapeutics stock is down over 22% in afternoon trading.Yesterday, SGMO stock closed at $19.05. The stock is … Pipeline | Sangamo Therapeutics, Inc. Sangamo’s robust and diverse pipeline of genomic medicines in clinical and preclinical stages of development encompass a breadth of distinct but complementary technical approaches. We are developing capabilities that allow us to design therapeutic approaches to resolve the underlying genetic causes of disease, using whichever technology is

Sangamo Therapeutics, Inc. (SGMO) Stock Price, Quote ...

Nov 05, 2019 · 3 Wall Street analysts have issued ratings and price targets for Sangamo Therapeutics in the last 12 months. Their average twelve-month price target is $13.00, suggesting that the stock has a possible upside of 109.34%. The high price target for SGMO is $16.00 and the low price target for SGMO is … Why Sangamo Therapeutics Stock Is Down More than 22% Today ...

Sangamo Therapeutics, Inc. - TheStreet - Stock Market